By ANI NEW DELHI: The Serum Institute of India (SII) and the Department of Biotechnology(DBT) are set to launch India’s first indigenously developed Quadrivalent...
Quadrivalent Human Papillomavirus vaccine
By Express News Service NEW DELHI: The Drugs Controller General of India (DCGI) on Tuesday granted market authorisation to the Serum Institute of India...
By PTI NEW DELHI: An expert panel of India’s central drug authority on Wednesday recommended granting of market authorisation to Serum Institute of India...